Implementation of a new Digi-HTA process for digital health technologies in Finland

12

Sep 2022

In August 2022, the Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) published an article regarding the implementation of a new Digi-HTA process for digital health technologies in Finland. This study aimed to determine whether it would be possible to use Digi-HTA recommendations to support healthcare decision-makers. Secondly, from the perspective of companies offering different types of digital health technology (DHT) products, this study assessed the suitability of using the Digi-HTA framework to perform HTAs for their products.

The following key conclusions were provided:

  • According to the healthcare professionals that participated in the study, the Digi-HTA recommendations contain clear and beneficial information. Better integration into decision-making processes would help them to make better use of these recommendations;
  • More awareness about the Digi-HTA recommendation process and its possibilities to support decision-makers is needed;
  • A low number of available Digi-HTA recommendations is seen as a barrier to utilizing the recommendations in the decision-making process;
  • The field of DHT covers a wide range of technology solutions, such as mHealth, digital platforms, artificial intelligence, and robotics. Responses of DHT companies to the survey indicate that the general-purpose Digi-HTA framework would be an applicable tool for performing assessments for DHT products that correspond to those surveyed;
  • Further development is still needed based on results, and the biggest improvement is needed for the usability and accessibility domain to make it comprehensive for all kinds of DHTs.

The Digi-HTA is an evaluation method for digital products and services for health care and social well-being. It is used to assess the suitability of a product or service; the assessment subareas mainly include effectiveness, safety, costs, data security and protection, usability, and accessibility.

The full details in Finnish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

16

Sep 2022

In August 2022, the National Institute for Health and Care Research (NIHR) in England released two MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned the treatment of urodynamic stress incontinence after prostate surgery and closure techniques after surgery for colorectal cancer. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

13

Sep 2022

In August 2022, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (aortic remodeling hybrid stent insertion during surgical repair of aortic dissection, bioresorbable stent implantation to treat coronary artery disease, superficial venous arterialization for chronic limb ischemia, transcutaneous electrical neuromuscular stimulation for urinary incontinence, focal resurfacing implants to treat articular cartilage damage in the knee), and three new Medtech Innovation Briefings (Stockholm3 for prostate cancer screening, contrast-enhanced spectral mammography, differential target multiplexed spinal cord stimulation). Also, two Medical Technologies Guidance and two Medtech-related clinical guidelines were updated.

Read more

09

Sep 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 15937 of August 4, 2022, Tuscany Regional Healthcare has published assessments of six medical devices in various therapeutic areas, such as cardiovascular and peripheral vascular areas, neurovascular procedures, gastroenterology, and dermatology.

Read more

07

Sep 2022

On August 26, 2022, Swedish Medical Technologies Product (MTP) Council announced ongoing horizon scanning within the Orderly introduction framework for products that promote the transition to so-called “Close care” (Nära vård). Products of interest should enable diagnosis, treatment, and follow-up outside a healthcare facility, for example, remote monitoring. The Dental and Pharmaceutical Benefits Agency (TLV) initiated a theme survey, accepting suggestions until September 28, 2022.

Read more

05

Sep 2022

On August 01, 2022, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) launched a new reimbursement framework for remote medical consultations. The Nomenclature was changed accordingly: a new article 37, “Remote care,” was introduced with four new codes and fees for video and telephone consultations by physicians.

Read more